Please login to the form below

Not currently logged in
Email:
Password:

Alexandre Lebeaut

This page shows the latest Alexandre Lebeaut news and features for those working in and with pharma, biotech and healthcare.

Ipsen’s liver cancer treatment clears phase III trial

Ipsen’s liver cancer treatment clears phase III trial

Cabometyx on track for new liver cancer indication

Latest news

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Accelerating innovation Accelerating innovation

    Accelerating innovation. Ipsen’s Alexandre Lebeaut on the French firm’s oncology plans, global focus and R&D approach. ... At the sharp end of this challenge is Ipsen’s chief scientific officer and executive VP, research and development, Alexandre

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Dr Sotirios Stergiopoulos leaves Shire for Ipsen Dr Sotirios Stergiopoulos leaves Shire for Ipsen

    His new role will see him report to Alexandre Lebeaut, executive vice-president R&D and chief scientific officer of Ipsen, who said: “Stergiopoulos has extensive experience in directing global medical

  • Ipsen appoints executive vice president Ipsen appoints executive vice president

    Ipsen appoints executive vice president. Alexandre Lebeaut also set to be chief scientific officer. ... Ipsen has appointed Dr Alexandre Lebeaut as its new executive VP, research and development, and chief scientific officer to focus on the firm’s

  • Ipsen boosts specialty care and R&D leadership teams Ipsen boosts specialty care and R&D leadership teams

    Meanwhile, Dr Stergiopoulos (pictured left) has been appointed as senior vice president and head of global medical affairs, reporting to R&D lead Dr Alexandre Lebeaut. ... Dr Lebeaut said: “ Sotirios brings extensive experience in directing global

  • Ipsen’s chief scientific officer steps down Ipsen’s chief scientific officer steps down

    Ipsen’ s chief scientific officer steps down. Dr Claude Bertrand will be replaced ad interim by Alexandre Lebeaut. ... He will be replaced by Dr Alexandre Lebeaut as interim head of research and development while the firm searches for a permanent

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics